Executive Compensation - Biotechnology

Company Executive Title Total Cash Total Compensation
MedImmune Inc. David M. Mott President, CEO and Vice Chairman $1,491,667.00$15,330,501.00
MedImmune Inc. Melvin D. Booth President and COO $908,334.00$5,521,279.00
MedImmune Inc. James F. Young, Ph.D. President/Research and Development $845,833.00$5,458,778.00
Human Genome Sciences Inc. William A. Haseltine, Ph.D. CEO $700,850.00$3,428,487.00
MedImmune Inc. Armando Anido, R.Ph. Senior Vice President $471,667.00$3,423,952.00
Novavax Inc. Nelson M. Sims President and CEO $157,692.00$3,344,303.00
MedImmune Inc. Wayne T. Hockmeyer, Ph.D. Chairman $950,000.00$3,256,472.00
Advancis Pharmaceutical Corp. Edward M. Rudnic President and CEO $465,000.00$3,256,163.00


© 2004 The Washington Post Company